Evidence map›Paper›PMID 29516368›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

Chemokine receptors: Key for molecular imaging of inflammation in atherosclerosis.

Yongjian Liu, Pamela K Woodard

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. PET Imaging Radiotracers of Chemokine Receptors.Molecules (Basel, Switzerland) · 2021
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Yongjian LiuMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Pamela K WoodardMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA. woodardp@mir.wustl.edu.

Funding

FIRST-IN-HUMAN TRIAL OF A RECEPTOR-TARGETED NANOPARTICLE PET TRACER FOR ATHEROSCLEROSISR01HL132600 · NHLBI · WASHINGTON UNIVERSITY · PI WOODARD, PAMELA K · 2017 to 2019
$2.2M
PET IMAGING CCR2 IN LUNG INFLAMMATIONR01HL131908 · NHLBI · WASHINGTON UNIVERSITY · PI BRODY, STEVEN, LIU, YONGJIAN · 2016 to 2018
$2.0M
CHEMOKINE RECEPTORS BASED NANOAGENTS IMAGING ATHEROSCLEROSISR01HL125655 · NHLBI · WASHINGTON UNIVERSITY · PI LIU, YONGJIAN · 2015 to 2018
$1.5M
NHLBI NIH HHS R01 HL125655NHLBI NIH HHS R01 HL131908NHLBI NIH HHS R01 HL132600
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AtherosclerosisMolecular ImagingAlanineAnimalsApolipoproteins EChemokinesCoordination ComplexesHeterocyclic Compounds, 1-RingIndium RadioisotopesInflammationMiceReceptors, CCR5Receptors, ChemokineAlanineApolipoproteins ECCR5 protein, mouseChemokinesCoordination ComplexesD-Ala-peptide T-amideHeterocyclic Compounds, 1-RingIndium-111indium-111-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acidIndium RadioisotopesReceptors, CCR5Receptors, Chemokine

Identifiers

PMID29516368
PMCPMC6128785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.